Compounds > norgestrel

norgestrel and Polycystic Ovarian Syndrome

norgestrel has been researched along with Polycystic Ovarian Syndrome in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adeniji, AA; Cheang, KI; Essah, PA; Nestler, JE1
Adawadkar, SS; Arrowood, JA; Cheang, KI; Essah, PA; Nestler, JE; Stovall, DW1
Mentha, G; Morel, P; Negro, F; Rubbia-Brandt, L; Toso, C1
Cibula, D; Fanta, M; Hill, M; Sindelka, G; Skrha, J; Zivny, J1
Perić, L; Prelević, G; Würzburger, M1
Anderson, DC; Evans, A; Mamtora, H; Mavroudis, K; Robertson, WR1

Trials

1 trial(s) available for norgestrel and Polycystic Ovarian Syndrome

ArticleYear
Effect of combined metformin and oral contraceptive therapy on metabolic factors and endothelial function in overweight and obese women with polycystic ovary syndrome.
    Fertility and sterility, 2011, Volume: 96, Issue:2

    Topics: Analysis of Variance; Biomarkers; Blood Glucose; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Endothelium, Vascular; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Hypoglycemic Agents; Inflammation Mediators; Insulin; Insulin Resistance; Lipids; Metformin; Norgestrel; Obesity; Overweight; Placebo Effect; Polycystic Ovary Syndrome; Time Factors; Treatment Outcome; Vasodilation; Virginia

2011

Other Studies

5 other study(ies) available for norgestrel and Polycystic Ovarian Syndrome

ArticleYear
Metabolic Effects of a Commonly Used Combined Hormonal Oral Contraceptive in Women With and Without Polycystic Ovary Syndrome.
    Journal of women's health (2002), 2016, Volume: 25, Issue:6

    Topics: Adult; Blood Glucose; Carbohydrates; Case-Control Studies; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Dose-Response Relationship, Drug; Estrogens; Ethinyl Estradiol; Female; Glucose Tolerance Test; Gonadal Steroid Hormones; Humans; Insulin; Lipid Metabolism; Lipids; Norgestrel; Polycystic Ovary Syndrome

2016
Hepatocellular adenoma and polycystic ovary syndrome.
    Liver international : official journal of the International Association for the Study of the Liver, 2003, Volume: 23, Issue:1

    Topics: Adenoma, Liver Cell; Adult; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Liver Neoplasms; Norgestrel; Polycystic Ovary Syndrome; Progesterone Congeners

2003
Insulin sensitivity in non-obese women with polycystic ovary syndrome during treatment with oral contraceptives containing low-androgenic progestin.
    Human reproduction (Oxford, England), 2002, Volume: 17, Issue:1

    Topics: Adult; Androstenedione; Blood Glucose; Body Constitution; Body Mass Index; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Fasting; Female; Glucose Clamp Technique; Humans; Insulin; Luteinizing Hormone; Metabolic Clearance Rate; Norgestrel; Polycystic Ovary Syndrome; Testosterone

2002
Serum testosterone response to low dose dexamethasone and combined contraceptive pill in subgroups of patients with polycystic ovary syndrome.
    Acta medica Iugoslavica, 1989, Volume: 43, Issue:2

    Topics: Dexamethasone; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Hirsutism; Humans; Norgestrel; Polycystic Ovary Syndrome; Testosterone

1989
Bioactive LH in women with polycystic ovaries and the effect of gonadotrophin suppression.
    Clinical endocrinology, 1988, Volume: 29, Issue:6

    Topics: Adolescent; Adult; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Menstrual Cycle; Norgestrel; Norpregnenes; Polycystic Ovary Syndrome; Progesterone; Progesterone Congeners

1988